Skip Navigation



Cardiovascular Research Advance Access [Accepted Manuscript] published online on January 10, 2008
Cardiovascular Research, doi:10.1093/cvr/cvn001
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
78/1/79    most recent
cvn001v2
cvn001v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Smeets, P. J.H.
Right arrow Articles by van Bilsen, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Smeets, P. J.H.
Right arrow Articles by van Bilsen, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2008. For permissions please email: journals.permissions@oxfordjournals.org

Cardiac hypertrophy is enhanced in PPAR{alpha}-/- mice in response to chronic pressure overload

Pascal J.H. Smeets1, Birgit E.J. Teunissen1, Peter H. M. Willemsen1, Frans A. van Nieuwenhoven1, Agnieszka E. Brouns2, Ben J.A. Janssen2, Jack P.M. Cleutjens3, Bart Staels4, Ger J. van der Vusse1 and Marc van Bilsen1,

1 Department of Physiology
2 Pharmacology & Toxicology
3 Pathology, Cardiovascular Research Institute Maastricht, Maastricht University, PO BOX 616, 6200 MD Maastricht, he Netherlands.
4 Unité 545, INSERM, Lille; Department of Atherosclerose, Institute Pasteur de Lille; Faculté de Pharmacie, Université de Lille II, Lille, F-59019, France.

Corresponding author: Dr. Marc van Bilsen Department of Physiology, Cardiovascular Research Institute Maastricht, Maastricht University PO BOX 616, 6200 MD Maastricht he Netherlands Marc.vanbilsen{at}fys.unimaas.nl Tel. (0031)(0)433881204 Fax. (0031)(0)433884166

Aim: Peroxisome proliferator-activated receptor-{alpha} (PPAR{alpha}) is a nuclear receptor regulating cardiac metabolism that also has anti-inflammatory properties. Since the activation of inflammatory signalling pathways is considered to be important in cardiac hypertrophy and fibrosis, it is anticipated that PPAR{alpha} modulates cardiac remodelling. Accordingly, in this study the hypothesis was tested that the absence of PPAR{alpha} aggravates the cardiac hypertrophic response to pressure overload.

Methods and results: Male PPAR{alpha}-/- and wild-type mice were subjected to transverse aortic constriction (TAC) for 28 days. TAC resulted in a more pronounced increase in ventricular weight and left ventricular (LV) wall thickness in PPAR{alpha}-/- than in wild-type mice. Compared to sham-operated mice, TAC did not affect cardiac function in wild-type mice, but significantly depressed LV ejection fraction and LV contractility in PPAR{alpha}-/- mice. Moreover, after TAC mRNA levels of hypertrophic (atrial natriuretic factor, {alpha}-skeletal actin), fibrotic (collagen 1, matrix metalloproteinase-2) and inflammatory (interleukin-6, tumour necrosis factor-{alpha}, cyclo-oxygenase-2) marker genes were higher in PPAR{alpha}-/- than in wild-type mice. The mRNA levels of genes involved in fatty acid metabolism (long-chain acyl-CoA synthetase, hydroxyacyl-CoA dehydrogenase) were decreased in PPAR{alpha}-/- mice, but were not further compromised by TAC.

Conclusions: The present findings show that the absence of PPAR{alpha} results in a more pronounced hypertrophic growth response and cardiac dysfunction that are associated with an enhanced expression of markers of inflammation and extracellular matrix remodelling. These findings indicate that PPAR{alpha} exerts salutary effects during cardiac hypertrophy.

KEYWORDS PPAR{alpha}; hypertrophy; metabolism; fibrosis; inflammation; pressure overload

Time for primary review: 37


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Cardiovasc ResHome page
C. Pellieux, C. Montessuit, I. Papageorgiou, and R. Lerch
Angiotensin II downregulates the fatty acid oxidation pathway in adult rat cardiomyocytes via release of tumour necrosis factor-{alpha}
Cardiovasc Res, May 1, 2009; 82(2): 341 - 350.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
L. Makowski, R. C. Noland, T. R. Koves, W. Xing, O. R. Ilkayeva, M. J. Muehlbauer, R. D. Stevens, and D. M. Muoio
Metabolic profiling of PPAR{alpha}-/- mice reveals defects in carnitine and amino acid homeostasis that are partially reversed by oral carnitine supplementation
FASEB J, February 1, 2009; 23(2): 586 - 604.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. GenomicsHome page
P. J. H. Smeets, H. M. de Vogel-van den Bosch, P. H. M. Willemsen, A. P. Stassen, T. Ayoubi, G. J. van der Vusse, and M. van Bilsen
Transcriptomic analysis of PPAR{alpha}-dependent alterations during cardiac hypertrophy
Physiol Genomics, December 12, 2008; 36(1): 15 - 23.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
P. J. H. Smeets, B. E. J. Teunissen, A. Planavila, H. de Vogel-van den Bosch, P. H. M. Willemsen, G. J. van der Vusse, and M. van Bilsen
Inflammatory Pathways Are Activated during Cardiomyocyte Hypertrophy and Attenuated by Peroxisome Proliferator-activated Receptors PPAR{alpha} and PPAR{delta}
J. Biol. Chem., October 24, 2008; 283(43): 29109 - 29118.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
M. Endoh
Novel signalling cascade for cardiac hypertrophy activation by uncoupling and internalization of {beta}1-adrenoceptors
Cardiovasc Res, April 1, 2008; 78(1): 5 - 7.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.